Chemed (NYSE:CHE) Price Target Raised to $625.00
Chemed (NYSE:CHE – Free Report) had its target price upped by Oppenheimer from $590.00 to $625.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have an outperform rating on the stock. CHE has been the subject of several other reports. Royal Bank of Canada boosted their price objective on Chemed […]
More Stories
Bridgemarq Real Estate Services Inc. (TSE:BRE) Increases Dividend to $0.11 Per Share
Bridgemarq Real Estate Services Inc. (TSE:BRE – Get Free Report) declared a monthly dividend on Friday, October 18th, TickerTech reports....
Whitecap Resources Inc. Plans Dividend of $0.04 (OTCMKTS:SPGYF)
Whitecap Resources Inc. (OTCMKTS:SPGYF – Get Free Report) declared a dividend on Saturday, October 19th, investing.com reports. Shareholders of record...
Origin Agritech (NASDAQ:SEED) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a research report report published on Friday....
Texas Capital Bancshares (NASDAQ:TCBI) Price Target Increased to $79.00 by Analysts at Hovde Group
Texas Capital Bancshares (NASDAQ:TCBI – Free Report) had its price target upped by Hovde Group from $73.00 to $79.00 in...
Bitcoiva Hits 1-Day Volume of $265,227.57 (BCA)
Bitcoiva (BCA) traded up 1.9% against the U.S. dollar during the 24-hour period ending at 7:00 AM ET on October...
Dent (DENT) Hits Market Cap of $89.23 Million
Dent (DENT) traded 1.4% higher against the dollar during the 1-day period ending at 7:00 AM E.T. on October 19th....